Your browser doesn't support javascript.
loading
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.
Morrow, C J; Trapani, F; Metcalf, R L; Bertolini, G; Hodgkinson, C L; Khandelwal, G; Kelly, P; Galvin, M; Carter, L; Simpson, K L; Williamson, S; Wirth, C; Simms, N; Frankliln, L; Frese, K K; Rothwell, D G; Nonaka, D; Miller, C J; Brady, G; Blackhall, F H; Dive, C.
Afiliação
  • Morrow CJ; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Trapani F; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Metcalf RL; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Bertolini G; Tumour Genomics Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Hodgkinson CL; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Khandelwal G; RNA Biology Group, University of Manchester, Manchester.
  • Kelly P; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Galvin M; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Carter L; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Simpson KL; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Williamson S; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Wirth C; Computational Biology Support Team, Cancer Research UK Manchester Institute, University of Manchester, Manchester.
  • Simms N; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Frankliln L; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Frese KK; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Rothwell DG; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Nonaka D; The Christie NHS Foundation Trust, Manchester.
  • Miller CJ; RNA Biology Group, University of Manchester, Manchester.
  • Brady G; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK.
  • Blackhall FH; The Christie NHS Foundation Trust, Manchester; Institute of Cancer Sciences, University of Manchester, Manchester; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK.
  • Dive C; Clinical and Experimental Pharmacology Group, University of Manchester, Manchester, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK. Electronic address: caroline.dive@cruk.manchester.ac.uk.
Ann Oncol ; 27(6): 1155-1160, 2016 06.
Article em En | MEDLINE | ID: mdl-27013395
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Carcinogênese / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Carcinogênese / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article